COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,625 Articles (22,913 medRxiv, 8,712 bioRxiv)

Most recent first Previous |  Page 2171: Articles 21701-21710  | Next

The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
Chan, C. E. Z., Seah, S. G. K., Chye, D. H., Massey, S., Torres, M., Lim, A. P. C., Wong, S. K. K., Neo, J. J. Y., Wong, P. S., Lim, J. H., Loh, G. S. L., Wang, D. L., Boyd-Kirkup, J. D., Guan, S., Thakkar, D., Teo, G. H., Purushotorman, K., Hutchinson, P. E., Young, B., Lye, D. C. B., Low, J. G., MacAry, P. A., Hentze, H., Prativadibhayankara, V. S., Ethirajulu, K., O'Connell, D., Comer, J., Tseng, C.-T. K., Barrett, A. D. T., Ingram, P. J., Brasel, T., Hanson, B. J.
10.1101/2020.10.26.355107 — Posted: 2020-10-26
SARS-CoV-2 specific memory T lymphocytes from COVID-19 convalescent donors: identification, biobanking and large scale production for Adoptive Cell Therapy
Ferreras, C., Pascual-Miguel, B., Mestre-Duran, C., Navarro-Zapata, A., Clares-Villa, L., Martin-Cortazar, C., De Paz, R., Marcos, A., Vicario, J. L., Balas, A., Garcia-Sanchez, F., Eguizabal, C., Solano, C., Mora-Rillo, M., Soria, B., Perez-Martinez, A.
10.1101/2020.10.23.352294 — Posted: 2020-10-26 Discussion: Onsite | Offsite
Tracking cytosine depletion in SARS-CoV-2
Luo, R., Wong, Y.-S., Lam, T.-W.
10.1101/2020.10.26.354787 — Posted: 2020-10-26
The genomic epidemiology of SARS-CoV-2 in Palestine
Qutob, N., Salah, Z., Richard, D., Darwish, H., Sallam, H., Shtayeh, I., Najjar, O., Balloux, F., van Dorp, L.
10.1101/2020.10.26.355677 — Posted: 2020-10-26
Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome
Bhatt, P. R., Scaiola, A., Loughran, G., Leibundgut, M., Kratzel, A., McMillan, A. E., O'Connor, K. M., Bode, J. W., Thiel, V., Atkins, J. F., Ban, N.
10.1101/2020.10.26.355099 — Posted: 2020-10-26 Discussion: Offsite
A theoretical analysis of the putative ORF10 protein in SARS-CoV-2
Schuster, N. A.
10.1101/2020.10.26.355784 — Posted: 2020-10-26
Clinical and laboratory characteristics in outpatient diagnosis of COVID-19 in healthcare professionals in Rio de Janeiro, Brazil
Porto, L. C., Costa, C. H., Nunes, A. S., Bouzas, I., Ferreira, T., Porto, V. M., Secco, D. A., COVID-19 PPC group, , Rufino, R.
10.1101/2020.10.22.20217851 — Posted: 2020-10-26
Lockdown related travel behavior undermines thecontainment of SARS-CoV-2
Kishore, N., Kahn, R., Martinez, P. P., De Salazar, P. M., Mahmud, A. S., Buckee, C.
10.1101/2020.10.22.20217752 — Posted: 2020-10-26
Hardness of Herd Immunity and Success Probability of Quarantine Measures: A Branching Process Approach
Nath, S. K.
10.1101/2020.10.22.20216481 — Posted: 2020-10-26
Characteristics associated with household transmission of SARS-CoV-2 in Ontario, Canada
Paul, L. A., Daneman, N., Brown, K. A., Johnson, J., van Ingen, T., Joh, E., Wilson, S. E., Buchan, S. A.
10.1101/2020.10.22.20217802 — Posted: 2020-10-26 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).